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Sclerosing  encapsulating  peritonitis  (SEP)  is  a  poorly  understood  and  rarely  documented  cause  of  small  bowel 
obstruction.  Although  recurrent  peritonitis  has  been  reported  as  the  main  contributory  factor  leading  to  secondary  SEP, 
the  pathogenesis  of  primary  (idiopathic)  SEP  is  still  uncertain. 
A  40-year-old  woman  with  a  history  of  total  abdominal  hysterectomy  due  to  gestational  trophoblastic  disease 
presented  with  progressive  lower  abdominal  pain  and  abdominal  distension.  Ultrasonography  and  contrast-enhanced 
abdomen-pelvis  computed  tomography  of  the  abdomen  revealed  encapsulation  of  the  entire  small  bowel  with  a 
sclerotic  capsule.  At  laparotomy,  a  fibrous  thick  capsule  encasing  small  bowel  loops  was  revealed.  Extensive 
adhesiolysis  and  removal  of  the  capsule  from  the  bowel  loops  were  performed.  The  patient  recovered  uneventfully;  she 
was  discharged  without  complications.
SEP  is  a  rare  cause  of  small  bowel  obstruction.  We  treated  a  case  of  abdominal  cocoon  with  intestinal  partial 
obstruction  in  a  woman  with  a  history  of  abdominal  hysterectomy  due  to  gestational  trophoblastic  disease.  Surgical 
treatment  was  effective  and  the  patient  recovered  without  complication.
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INTRODUCTION
Sclerosing  encapsulating  peritonitis  (SEP),  characterized  by  a 
thick  and  fibrotic  membrane,  is  a  rare  cause  of  small  bowel 
obstruction;  its  pathogenesis  is  poorly  understood
1, 2, 4).   
Idiopathic  SEP,  also  known  as  abdominal  cocoon,  was  first 
described  in  young  girls  by  Foo  et  al.;  it  was  thought  to  be 
caused  by  a  low-grade  peritonitis  from  retrograde  menstrua-
tion
3).  However,  subsequently  there  were  sporadic  reports  in 
older  patients  of  both  genders
4).  Secondary  SEP  occurs  most 
frequently  in  patients  on  chronic  ambulatory  peritoneal  dialysis
5, 6). 
Here,  we  report  a  case  of  sclerosing  encapsulating  peritonitis 
with  partial  small  bowel  obstruction  that  developed  3  years  after 
abdominal  hysterectomy  for  gestational  trophoblastic  disease. 
CASE REPORT
A  40-year-old  woman  presented  with  a  history  of  progressive 
lower  abdominal  pain,  abdominal  distension  and  frequent  gas  of 
2  years  duration.  The  patient  had  a  history  of  abdominal 
hysterectomy  for  gestational  trophoblastic  disease  3  years  prior 
to  presentation.  .  The  patient  reported  intermittent  episodes  of 
abdominal  colicky  pain  and  bloating  after  a  meal  two  years  post 
surgery.  The  symptoms  were  becoming  more  frequent  and 
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Figure  1.  Plain  abdominal  X-ray  shows  marked  small  bowel  dilatation  and  air  collection  in  the  lumen  with 
multiple  air  fluid  levels  in  the  upright  position.  The  distended  bowel  loop  was  located  centrally  and  extensively 
folded  (A:  supine  position,  B:  upright  position).
Figure  2.  Ultrasound  of  the  abdomen  shows  small  bowel 
surrounded by a continuous membranous structure. The thickness 
of  the  capsule  was  from  3.5  mm  up  to  6.1  mm.
diabetes  mellitus,  liver  disease  or  medication. 
On  physical  examination,  the  patient  was  afebrile  and 
hemodynamically  stable.  The  abdomen  was  distended  but 
non-tender  with  increased  bowel  sounds  in  pitch  and  frequency. 
No  palpable  mass  or  organomegaly  and  no  external  hernias 
were  present.  Laboratory  blood  analyses  including  erythrocyte 
sedimentation  rate  (ESR)  and  C-reactive  protein  (CRP)  were 
within  normal  limits.  Plain  abdominal  X-ray  showed  marked 
small  bowel  dilatation  and  air  collection  with  air-fluid  levels 
centrally  located  (Figure  1).  Ultrasonography  of  the  abdomen 
revealed  that  the  small  bowel  was  surrounded  by  a 
membranous  structure  with  a  thickness  from  3.5  mm  to  6.1  mm 
(Figure  2).  The  patient  was  admitted  to  the  general  ward  of  our 
hospital  with  the  impression  of  intestinal  obstruction. 
Contrast-enhanced  abdomen-pelvis  computed  tomography 
performed  initially  showed  encapsulation  of  the  entire  small 
bowel  with  a  sclerotic  capsule,  without  a  luminal  obstructive 
lesion  or  ischemic  change  of  the  small  bowel  (Figure  3).  There 
was  also  a  small  amount  of  ascites  in  the  pelvic  cavity  and 
several  slightly  enlarged  lymph  nodes  at  the  ileocolic  area  by 
CT  scan.  Endoscopy  of  the  upper  gastrointestinal  tract  did  not 
demonstrate  any  abnormalities  except  a  short  segment  of 
Barrett's  esophagus.  A  barium  follow-through  study  of  the  small 
bowel,  performed  in  order  to  evaluate  the  continuity  or  stenotic 
change  in  the  small  bowel,  revealed  dilated  and  aggregated 
small  bowel  with  normal  peristalsis,  suggesting  abdominal 
cocoon  (Figure  4).  The  ileus  was  resolved  with  conservative 
care  over  3  days;  the  patient  was  advanced  to  a  liquid  diet; 
however,  she  complained  of  abdominal  pain  again.  An 
abdominal  computed  tomography  with  gastrograffin  was  carried 
out;  the  small  bowel  was  encapsulated  from  the  distal  jejunum 
to  the  mid  ileum  with  adhesion  of  bowel  loops  and  preservation 
of  passage  through  the  entire  bowel  (Figure  3).
Laparotomy  exploration  was  finally  performed  for 
encapsulating  peritonitis  with  intestinal  partial  obstruction. 
Exploration  revealed  encapsulation  of  the  entire  bowel  with  a 
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Figure  3.  (A)  Contrast-enhanced  abdomen-pelvis  computed 
tomogram  shows  encapsulation  of  the  entire  small  bowel  with  a 
sclerotic capsule. (B) Abdomen computed tomogram after intake of 
gastrograffin  shows  encapsulation  of  the  small  bowel  from  the 
distal  jejunum  to  the  mid  ileum.
Figure  4.  Barium  follow-through  shows  the  entire  dilated  small 
bowel loop aggregated and deviated to left side of abdomen. There 
was  no  ulcerative  change  or  obstructive  material  in  the  lumen  of 
the  bowel  and  normal  peristalsis.  A  trace  of  barium  in  the 
ascending colon  suggested little continuity from  the  small  bowel to 
the  colon.
whitish  leather-like  fibrous  membrane  and  straw-colored  ascitic 
fluid  of  a  moderate  amount  (Figure  5).  In  addition,  there  was 
adhesion  between  the  liver  and  gall  bladder  with  a  whitish 
fibrous  band,  but  no  nodular  change  on  the  surface  of  the  liver. 
An  adhesiolysis  of  the  capsule  encasing  bowel  revealed  the 
serosa  of  the  bowel  loops  attached  to  one  another  by  a  thin 
flimsy  layer,  which  could  be  separated  easily.  The  pathologic 
finding  of  the  removed  capsule  was  a  dense  collagenous 
fibrous  tissue  with  mild  chronic  inflammation  (Figure  6).  After 
surgery,  the  patient  was  tolerated  a  gradually  increased  diet 
without  any  complication  and  was  discharged,  on  hospital  day  22.
DISCUSSION
Sclerosing  encapsulating  peritonitis  is  an  uncommon  but 
potentially  lethal  condition.  It  can  lead  to  severe  complications 
such  as  bowel  obstruction,  enterocutaneous  fistulas  and 
necrosis.  Most  cases  are  diagnosed  incidentally  at  laparotomy. 
Preoperative  diagnosis  is  confirmed  readily  by  a  combination  of 
barium  follow-through  where  a  concertina  pattern  or  cauliflower 
sign  and  delayed  transit  of  contrast  medium  are  characteristic 
and  computed  tomography  of  the  abdomen  where  images  show 
small  bowel  loops  aggregated  together  at  the  center  of  the 
abdomen  encased  by  a  soft-tissue  density  mantle
7, 8).   
  The  management  for  SEP  includes  medical  treatment  and 
surgical  intervention.  Therapy  with  corticosteroids  is  effective  in 
patients  with  secondary  SEP.  Tamoxifen,  a  nonsteroidal 
anti-estrogen  drug,  has  been  successfully  used  in  the  treatment 
of  fibrosclerotic  disorders
9, 10).  Surgery,  such  as  membrane 
A
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Figure  5.  Laparotomy  exploration  revealed  encapsulation  of  the  entire  small  bowel  with  a  whitish  leather  like  fibrous  membrane. 
Adhesiolysis  of  the  capsule  encasing  the  bowel  was  performed.
 
Figure  6.  The  microscopic  findings  of  the  capsule  shows  dense  collagenous  fibrous  tissue  with  mild  chronic  inflammation  (A:  ×100,  B: 
×200,  H  &  E  stain).
dissection  and  extensive  adhesiolysis,  is  the  treatment  of  choice 
for  cases  with  intestinal  obstruction.  However,  due  to  morbidity 
and  mortality,  resection  of  bowel  is  indicated  only  if  the  bowel  is 
non-viable  or  is  not  completely  separated  from  the  capsule  due 
to  severe  adhesion. 
  The  pathogenesis  of  SEP  remains  uncertain.  However, 
recurrent  peritonitis  has  been  reported  as  the  main  cause  of 
secondary  SEP
5, 6).  Other  factors  that  may  lead  to  SEP  include 
the  following.  Sterilizing  chemicals,  buffers,  hypertonic  dextrose, 
chronic  use  of  β-blocking  agent,  acidic  dialysate,  peritoneal 
catheter  itself,  drugs  added  to  dialysis  fluid,  and  endotoxin 
contamination  of  in  line  microbiologic  filters
11, 12).  Rarely,  SEP  is 
also  associated  with  abdominal  tuberculosis,  sarcoidosis,  familial 
Mediterranean  fever,  gastrointestinal  malignancy,  protein-S 
deficiency,  liver  transplantation,  fibrogenic  foreign  material,  and 
luteinized  ovarian  thecomas
13). 
This  report  describes  a  case  of  abdominal  cocoon  in  a 
Korean  woman  with  intermittent  partial  obstruction  of  small 
bowel.  Accurate  pre-operative  diagnosis  makes  it  possible  for 
the  surgeon  to  perform  extensive  adhesiolysis  and  removal  of 
the  capsule  encasing  small  bowel  without  resection  of  the 
bowel.  The  patient  had  no  history  of  chronic  continuous 
peritoneal  dialysis  but  had  a  history  of  chronic  abdominal  pain 
after  hysterectomy.  There  has  been  no  report  on  the 
association  of  SEP  with  hysterectomy  or  gestational 
trophoblastic  disease  to  date.  There  are  a  few  reports  of 
abdominal  cocoon  in  patients  with  liver  transplantation  or 
treatment  for  liver  cirrhosis  who  did  not  have  a  history  of 
peritoneal-venous  shunting  (PVS)  or  β-blocker  medication. 
These  findings  suggest  that  sclerosing  peritonitis  may  be  due  to 
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persistent  low-grade  intra-abdominal  sepsis
14, 15).  Nakamura  et 
al.  reported  that  SEP  pathogenesis  in  long-term  CAPD  patients 
might  be  related  to  advanced  glycation  end-product 
accumulation  in  the  peritoneal  membrane  and  alteration  in 
peritoneal  cell  function,  accompanied  by  increased  expression  of 
various  growth  factors  and  peritoneal  sclerosis,  and  finally 
followed  by  SEP.  Therefore,  long-term  peritoneal  stimulation 
with  certain  products  associated  with  peritonitis,  of  various 
causes,  could  cause  SEP
16).  In  our  case,  SEP  may  have  been 
associated  with  chronic  and  recurrent  peritonitis  after  abdominal 
open  surgery. 
  The  causes  of  SEP  may  be  much  more  diverse  than 
previously  thought.  Study  of  additional  SEP  cases  is  needed  to 
facilitate  precise  and  rapid  diagnosis  and  treatment  as  well  as 
considerations  for  prevention. 
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